Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H12FNO3 |
Molecular Weight | 261.2484 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O
InChI
InChIKey=DPSPPJIUMHPXMA-UHFFFAOYSA-N
InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)
Molecular Formula | C14H12FNO3 |
Molecular Weight | 261.2484 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Flumequine is a synthetic antibiotic, which used to treat urinary tract infections until toxicity studies were reported. Flumequine inhibits bacterial enzyme DNA gyrase (topoisomerase) that is responsible for the supercoiling of DNA, thus bacterial cell growth disrupted by inhibiting nucleic acid synthesis.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora. | 2005 |
|
Validation of a novel HPLC sorbent material for the determination of ten quinolones in human and veterinary pharmaceutical formulations. | 2005 Dec |
|
Multiresidue method for simultaneous determination of ten quinolone antibacterial residues in multimatrix/multispecies animal tissues by liquid chromatography with fluorescence detection: single laboratory validation study. | 2005 Jul-Aug |
|
Oxidative transformation of fluoroquinolone antibacterial agents and structurally related amines by manganese oxide. | 2005 Jun 15 |
|
Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. | 2005 May |
|
Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria. | 2005 May 20 |
|
Flumequine in the goat: pharmacokinetics after intravenous and intramuscular administration. | 2005 Nov |
|
Efficacy of orally administered flumequine in the treatment of vibriosis caused by Listonella anguillarum in atlantic cod Gadus morhua. | 2005 Nov 9 |
|
Multiresidue determination of eleven quinolones in milk by liquid chromatography with fluorescence detection. | 2005 Nov-Dec |
|
Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms. | 2005 Oct 31 |
|
Interactions of fluoroquinolone antibacterial agents with aqueous chlorine: reaction kinetics, mechanisms, and transformation pathways. | 2005 Sep 15 |
|
Evaluation of certain veterinary drug residues in food. Sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. | 2006 |
|
High-throughput screening for multi-class veterinary drug residues in animal muscle using liquid chromatography/tandem mass spectrometry with on-line solid-phase extraction. | 2006 |
|
Simultaneous determination of (fluoro)quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA). | 2006 Apr 19 |
|
Ecotoxicity of mixtures of antibiotics used in aquacultures. | 2006 Aug |
|
Gene expression analysis in mice liver on hepatocarcinogenesis by flumequine. | 2006 Aug |
|
Confirmatory and quantitative analysis using experimental design for the extraction and liquid chromatography-UV, liquid chromatography-mass spectrometry and liquid chromatography-mass spectrometry/mass spectrometry determination of quinolones in turkey muscle. | 2006 Dec 1 |
|
Determination of fluoroquinolones in milk samples by postcolumn derivatization liquid chromatography with luminescence detection. | 2006 Dec 27 |
|
Fluoroquinolone-resistant Salmonella sp. in carcasses. | 2006 Feb |
|
Evaluation of the Premi Test and comparison with the One-Plate Test for the detection of antimicrobials in kidney. | 2006 Feb |
|
Determination of fluoroquinolones in chicken tissues by LC-coupled electrospray ionisation and atmospheric pressure chemical ionisation. | 2006 Jan |
|
Efficient approach for the reliable quantification and confirmation of antibiotics in water using on-line solid-phase extraction liquid chromatography/tandem mass spectrometry. | 2006 Jan 20 |
|
Determination of quinolone residues in chicken and fish by capillary electrophoresis-mass spectrometry. | 2006 Jun |
|
Drug resistance and random amplified polymorphic DNA analysis of Photobacterium damselae ssp. piscicida isolates from cultured Seriola (yellowtail, amberjack and kingfish) in Japan. | 2006 Jun |
|
Multiresidue method for the determination of quinolone antibiotics in bovine raw milk by capillary electrophoresis-tandem mass spectrometry. | 2006 Nov 15 |
|
Chromatographic determination of flumequine in food samples by post-column derivatisation with terbium(III). | 2006 Sep 25 |
|
Improved microbial screening assay for the detection of quinolone residues in poultry and eggs. | 2007 Aug |
|
Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates. | 2007 Fall |
|
Impacts of waste from concentrated animal feeding operations on water quality. | 2007 Feb |
|
[Residues of tetracycline and quinolones in wild fish living around a salmon aquaculture center in Chile]. | 2007 Feb |
|
Biotransformation of flumequine by the fungus Cunninghamella elegans. | 2007 Feb |
|
Adsorption and oxidation of fluoroquinolone antibacterial agents and structurally related amines with goethite. | 2007 Jan |
|
Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice. | 2007 Jan |
|
Visible-light-Mediated TiO2 photocatalysis of fluoroquinolone antibacterial agents. | 2007 Jul 1 |
|
Determination of quinolone residues in shrimp using liquid chromatography with fluorescence detection and residue confirmation by mass spectrometry. | 2007 Jul 23 |
|
Separation of fifteen quinolones by high performance liquid chromatography: application to pharmaceuticals and ofloxacin determination in urine. | 2007 Jun |
|
Toxicity evaluation with Vibrio fischeri test of organic chemicals used in aquaculture. | 2007 Jun |
|
Multiresidue determination of quinolone antibacterials in eggs of laying hens by liquid chromatography with fluorescence detection. | 2007 Jun 1 |
|
Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds. | 2007 Jun 15 |
|
Microbiological detection of 10 quinolone antibiotic residues and its application to artificially contaminated poultry samples. | 2007 Mar |
|
Retention of quinolones on human serum albumin and alpha1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity. | 2007 Mar |
|
Biosensor immunoassay for flumequine in broiler serum and muscle. | 2007 Mar 14 |
|
Dual biosensor immunoassay-directed identification of fluoroquinolones in chicken muscle by liquid chromatography electrospray time-of-flight mass spectrometry. | 2007 Mar 14 |
|
Multiresidue determination of quinolone and fluoroquinolone antibiotics in fish and shrimp by liquid chromatography/tandem mass spectrometry. | 2007 Mar-Apr |
|
Simultaneous determination of trace levels of 10 quinolones in swine, chicken, and shrimp muscle tissues using HPLC with programmable fluorescence detection. | 2007 May 16 |
|
Simultaneous determination of different classes of antibiotics in fish and livestock by CE-MS. | 2007 Nov |
|
Development and validation of an HPLC confirmatory method for residue analysis of ten quinolones in tissues of various food-producing animals, according to the European Union Decision 2002/657/EC. | 2007 Nov |
|
Multiresidue HPLC analysis of ten quinolones in milk after solid phase extraction: validation according to the European Union Decision 2002/657/EC. | 2007 Oct |
|
Simultaneous determination of selected veterinary antibiotics in gilthead seabream (Sparus Aurata) by liquid chromatography-mass spectrometry. | 2007 Sep 15 |
|
Oral bioavailability, tissue distribution and depletion of flumequine in the food producing animal, chicken for fattening. | 2008 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3356617
400 mg bd. Duration of treatment ranged from 7-15 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12377980
Curator's Comment: It was investigated the potential of flumequine to inhibit eukaryotic topoisomerase II, which is responsible for the double-strand DNA breakage reaction as well as bacterial gyrase, inhibitory effects of flumequine on topoisomerase II were high relative to the influence on bacterial gyrase.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:29:31 GMT 2025
by
admin
on
Wed Apr 02 09:29:31 GMT 2025
|
Record UNII |
UVG8VSP2SJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C795
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
||
|
WHO-VATC |
QJ01MB07
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
||
|
WHO-ATC |
J01MB07
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
25112
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000080686
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
255-962-6
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL370252
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
85267
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
UVG8VSP2SJ
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
DB08972
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
DTXSID5045623
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
C012976
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
FLUMEQUINE
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
SUB07696MIG
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
C80639
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
7034
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
3374
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
42835-25-6
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
757806
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
3776
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | |||
|
m5438
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
1197
Created by
admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |